Ayrton Capital LLC - IBERE PHARMACEUTICALS ownership

Back to all holdings Add to watchlist

IBERE PHARMACEUTICALS's ticker is IBERWS and the CUSIP is G46843119. A total of 2 filers reported holding IBERE PHARMACEUTICALS in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
Ayrton Capital LLC ownership history of IBERE PHARMACEUTICALS
ValueSharesWeighting
Q4 2022$505
-74.8%
28,3930.0%0.00%
-75.0%
Q3 2022$2,0000.0%28,3930.0%0.00%
+33.3%
Q2 2022$2,000
-66.7%
28,3930.0%0.00%
-62.5%
Q1 2022$6,000
-60.0%
28,3930.0%0.01%
-42.9%
Q4 2021$15,000–28,393–0.01%–
 Download
Other shareholders
IBERE PHARMACEUTICALS shareholders Q1 2023
NameSharesValueWeighting ↓
Lynwood Capital Management Inc. 9,800$108,0540.10%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of IBERE PHARMACEUTICALS shareholders